Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
China · Delayed Price · Currency is CNY 31.68
+1.75 (5.85%)
Aug 20, 2026, 3:00 PM CST
SHA:603538 Market Cap
SHA:603538 has a market cap or net worth of 10.77 billion as of August 20, 2026. Its market cap has increased by 68.75% in one year.
Market Cap
10.77B
Enterprise Value
11.00B
Revenue
1.68B
Ranking
n/a
PE Ratio
84.98
Stock Price
31.68
ChartMarket Cap Chart
Since April 7, 2017, SHA:603538's market cap has increased from 2.42B to 10.77B, an increase of 344.26%. That is a compound annual growth rate of 17.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 10.77B | 153.69% |
| Dec 31, 2025 | 4.24B | 52.67% |
| Dec 31, 2024 | 2.78B | -31.86% |
| Dec 29, 2023 | 4.08B | -25.74% |
| Dec 30, 2022 | 5.49B | 3.44% |
| Dec 31, 2021 | 5.31B | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 7, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guobang Pharma | 12.03B |
| Porton Pharma Solutions | 11.87B |
| Shanghai Shyndec Pharmaceutical | 11.67B |
| Zhejiang Jingxin Pharmaceutical | 11.41B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 11.10B |
| Henan Lingrui Pharmaceutical | 11.05B |
| Tianjin Chase Sun Pharmaceutical Co.,Ltd | 10.94B |
| Yantai Dongcheng Pharmaceutical Group | 10.76B |